- Headquarters
- Cambridge, Massachusetts, United States · North America
- Value chain
- Medicines & vaccines(Products); also Research & IP
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 2010
- Staff
- 5,800 (2024)
- Ownership
- Listed
- Listing
- Nasdaq:MRNA on Google Finance
- Website
- modernatx.com
- Relevance
- Very high at its strongest, in Advanced Therapeutics, Vaccines & Medical Countermeasures
Cambridge, Massachusetts, United StatesIn 2 capabilities
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #2 of 50
mRNA platform company behind Spikevax (COVID-19) and mRESVIA (RSV), with a pipeline of mRNA vaccines for influenza, CMV and individualized cancer vaccines.
Relevance: mRNA platform leader
- BiomanufacturingModerate
Biotechnology & Health Technologies · Manufacture · listed #23 of 50
Built the first commercial-scale mRNA vaccine manufacturing and is establishing sovereign mRNA plants in Canada, the UK and Australia.
Relevance: Pioneered commercial-scale mRNA manufacturing